Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Australian Clinical Labs Ltd has announced a daily update on its ongoing on-market buy-back program, with a total of 1,205,864 shares bought back prior to the latest day and an additional 33,391 shares bought back on the previous day. This strategic move is part of the company’s efforts to enhance shareholder value and optimize capital structure.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.